Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Dendritic cells are unique in their capacity to process antigens and prime naive CD8(+) T cells. Contrary to most cells, which express the standard proteasomes, dendritic cells express immunoproteasomes constitutively. The melanoma-associated protein Melan-A(MART1) contains an HLA-A2-restricted peptide that is poorly processed by melanoma cells expressing immunoproteasomes in vitro. Here, we show that the expression of Melan-A in dendritic cells fails to elicit T-cell responses in vitro and in vivo because it is not processed by the proteasomes of dendritic cells. In contrast, dendritic cells lacking immunoproteasomes induce strong anti-Melan-A T-cell responses in vitro and in vivo. These results suggest that the inefficient processing of self-antigens, such as Melan-A, by the immunoproteasomes of professional antigen-presenting cells prevents the induction of antitumor T-cell responses in vivo.

Original publication




Journal article


Cancer Res

Publication Date





5461 - 5468


Animals, Antigen Presentation, Antigens, Neoplasm, Cysteine Endopeptidases, Dendritic Cells, HLA-A2 Antigen, Humans, Immunotherapy, Adoptive, Lymphocyte Activation, MART-1 Antigen, Mice, Mice, Transgenic, Neoplasm Proteins, Proteasome Endopeptidase Complex, T-Lymphocytes, T-Lymphocytes, Cytotoxic